Sizzling update why Cleveland BioLabs, Inc. (CBLI) shares surged on Friday night
Cleveland BioLabs, Inc. (NASDAQ: CBLI) stock was tossed up almost 30% to $3.7 in the late hours on Friday after the reports that in connection with the merger of CBLI with Cytocom, the Lifshitz Law Firm, P.C. is investigating possible breaches of fiduciary duties. CBLI investors who wish to learn more about our investigation should […]
This hot update rushed CTD Holdings Inc. (CYTH) in the Pre-market session
CTD Holdings Inc. (NASDAQ: CYTH) a biotechnology company that develops cyclodextrin-based products for the treatment of diseases rushed in the pre-market session more than 70% to $8.15 after the Analysts from the Maxim Group upgraded the stock to BUY with the price of $12.00. CTD Holdings Inc. (NASDAQ: CYTH) stock has a Market Cap of […]
Is that why Mesoblast Limited (MESO) dipped in the early morning trading?
Mesoblast Limited (Nasdaq:MESO) shares were plunging -30.07 to $9.45 in the premarket session recently released an update on the clinical trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome (ARDS) caused by infection with COVID-19 following a third interim analysis of the first 180 patients in the trial by the […]
Applied DNA Sciences (APDN) shares took a blow in after-hours after this huge update
Applied DNA Sciences (APDN) stock fumbled in the after-market as in its Q4 financial report announced, the company reported a loss and missed revenue estimates. The company lost $0.82 per share in its most recent quarter, compared with a $0.59 per share in the previous quarter. This compares to a loss of $1.44 per share […]
Which Stocks Are Moving Today?
Avenue Therapeutics Inc. (NASDAQ:ATXI) shares traded over 29.00% higher in trading on Thursday after providing regulatory update for IV Tramadol. The consensus recommendation for the company is moderate buy. Shares of Phunware Inc. (PHUN) are 26.44% higher in trading this morning. Ascendiant Capital Markets issued a Buy recommendation for Phunware Inc. with a target price […]
Does This update cause Uxin Limited’s (UXIN) stock to go downhill?
Uxin Limited (NASDAQ: UXIN) share plunged -12.14% to 1.230 in the pre-market session after unaudited financial results for Company’s second quarter ended September 30, 2020, were released today. Last quarter Earnings Highlights During the three months ended September 30, 2020, 2C transaction volume (completed with the use of online sales) was 2,653 units higher than […]
Premarket Stock Gainers
Pre-market data show Xunlei Limited (NASDAQ:XNET) is 7.89% higher at $3.28. It recently closed at $3.04, fluctuating in a day’s range from $2.94 to $3.44 and a 52-week trading range of $2.38 to $5.94. 9 Meters Biopharma Inc. (NASDAQ:NMTR) is trading at $0.9 up with 19.21 percent or 0.15 point in pre-market trading today after […]
What made Wunong Net Technology (WNW) shares sky-rocketed in the early morning today
Wunong Net Technology Co. Ltd., also known as WNW, Shares rocketed 440.4% to reach 65.10 in the pre-market trading as an e-commerce company with a platform to sell many food items on the internet, recently revealed the pricing of its initial public offering (IPO) of their 5,000,000 ordinary shares and expects total gross proceeds of […]
Top news pushed Marathon Patent Group (MARA) shares higher in the Early-morning trading
Although Marathon Patent Group (NASDAQ: MARA) has not released any new information this week, its stock is still on the rise in the pre-market session today. The Company’s stock was trading higher 18.40% to reach $9.70. As of this writing, more than 25 million shares of MARA stock have changed hands. To put that in […]
Hot update initiated MacroGenics, Inc. (MGNX) surge in the Post-market session
MacroGenics, Inc. (NASDAQ: MGNX), shares zipped 13.27% in the post-market to reached $28. A biopharmaceutical corporation devoted to the production and promotion of novel cancer medication monoclonal antibody-based therapeutics has confirmed that the U.S. MARGENZA, in combination with chemotherapy, has been regulated by the FDA for the treatment of adult patients with metastatic HER2-positive breast cancer […]
